ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,571, issued on April 21, was assigned to Turning Point Therapeutics Inc. (Princeton, N.J.).

"Macrocyclic compounds and uses thereof" was invented by Jingrong Jean Cui (Princeton, N.C.), Evan W. Rogers (Princeton, N.J.), Jane Ung (Princeton, N.J.), Jeffrey Whitten (Princeton, N.J.), Dayong Zhai (Princeton, N.J.), Wei Deng (Princeton, N.J.), Xin Zhang (Princeton, N.J.), Zhongdong Huang (Princeton, N.J.), Jing Liu (Princeton, N.J.) and Han Zhang (Princeton, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing su...